Minerva’s Artron gives liquid joint-pain relief
This article was originally published in OTC Bulletin & The Rose Sheet
“Now joint care starts with a sip” is the tagline for Minerva Research Labs’ new Artron Collagen liquid food supplement in the UK, which the firm said was the first joint-care supplement based on its “scientifically- proven” European Union (EU) patentpending bioactive collagen complex.
You may also be interested in...
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.
Two late-stage trials of Austedo have missed their endpoints in the neurological disorder, meaning Teva will miss out on an additional revenue stream from the VMAT2 inhibitor.
Sandoz US president Carol Lynch talked to Scrip about its changing US portfolio, which will emphasize biosimilars, as the Novartis unit is poised to divest most of its US generics portfolio to Aurobindo.